Autoantibodies in post-treatment Lyme disease syndrome. | Front Neurol;13: 1004853, 2022. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Autoantibodies in post-treatment Lyme disease syndrome.

Alaedini, Armin; Wormser, Gary P.

Alaedini A; Department of Medicine, Columbia University, New York, NY, United States.
Wormser GP; Institute of Human Nutrition, Columbia University, New York, NY, United States.

Front Neurol ; 13: 1004853, 2022.

Article in English | MEDLINE | ID: covidwho-2227246

Keywords

Borrelia burgdorferi; COVID-19; Lyme disease; autoantibody; immunoassay; infection; inflammation; post-treatment Lyme disease syndrome

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Long Covid Language: English Journal: Front Neurol Year: 2022 Document Type: Article Affiliation country: Fneur.2022.1004853

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Long Covid Language: English Journal: Front Neurol Year: 2022 Document Type: Article Affiliation country: Fneur.2022.1004853